MDT
96.14
-0.57%↓
A
136.19
-1%↓
VEEV
223.11
-0.69%↓
HQY
91.51
-0.5%↓
PHR.US
16.9
-0.59%↓
MDT
96.14
-0.57%↓
A
136.19
-1%↓
VEEV
223.11
-0.69%↓
HQY
91.51
-0.5%↓
PHR.US
16.9
-0.59%↓
MDT
96.14
-0.57%↓
A
136.19
-1%↓
VEEV
223.11
-0.69%↓
HQY
91.51
-0.5%↓
PHR.US
16.9
-0.59%↓
MDT
96.14
-0.57%↓
A
136.19
-1%↓
VEEV
223.11
-0.69%↓
HQY
91.51
-0.5%↓
PHR.US
16.9
-0.59%↓
MDT
96.14
-0.57%↓
A
136.19
-1%↓
VEEV
223.11
-0.69%↓
HQY
91.51
-0.5%↓
PHR.US
16.9
-0.59%↓
24h
Šī brīža
Min
44.7
Max
45.34
Ienākumi | 34M 130M |
|---|---|
Pārdošana | -957K 533M |
P/E Sektora vidējais | 24.516 88.032 |
EPS | 0.61 |
Dividenžu ienesīgums | 0.55 |
Peļņas marža | 24.417 |
Darbinieki | 5,700 |
EBITDA | 93M 277M |
Rekomendācijas | Pirkt |
|---|---|
Prognoze 12 mēnešiem | +11.63% upside |
Dividenžu ienesīgums Sektora vidējais | 0.55% 2.26% |
|---|---|
Nākamie ieņēmumi | 2026. g. 4. febr. |
Tirgus kapitalizācija | -17M 9.9B |
|---|---|
Iepriekšējā atvēršanas cena | 45.78 |
Iepriekšējā slēgšanas cena | 44.96 |
By Acuity
27%
73%
63 / 374 Rangs Healthcare
Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.
2025. g. 31. dec. 22:20 UTC
Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug
DJ
Lasīt
2025. g. 31. dec. 17:31 UTC
OwlTing Climbs on Launch of $10 Million Stock-Buyback Program
DJ
Lasīt
2025. g. 31. dec. 16:30 UTC
Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders
DJ
Lasīt
2025. g. 31. dec. 15:19 UTC
Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing
DJ
Lasīt
2025. g. 31. dec. 15:17 UTC
Nike Shares Rise After CEO Hill Buys $1 Million of Shares
DJ
Lasīt
2025. g. 31. dec. 14:37 UTC
Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application
DJ
Lasīt
2025. g. 31. dec. 21:50 UTC
Basic Materials Roundup: Market Talk
DJ
Lasīt
2025. g. 31. dec. 21:13 UTC
10 People to Watch in Wealth Management in 2026 -- Barrons.com
DJ
Lasīt
2025. g. 31. dec. 20:40 UTC
Dollar Posting Its Worst Year Since 2017 -- Market Talk
DJ
Lasīt
2025. g. 31. dec. 20:22 UTC
Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk
DJ
Lasīt
2025. g. 31. dec. 19:50 UTC
U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk
DJ
Lasīt
2025. g. 31. dec. 19:31 UTC
Precious Metals Cap Off Record Runs -- Market Talk
DJ
Lasīt
2025. g. 31. dec. 18:50 UTC
Global Equities Roundup: Market Talk
DJ
Lasīt
2025. g. 31. dec. 18:50 UTC
Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk
DJ
Lasīt
2025. g. 31. dec. 17:17 UTC
U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk
DJ
Lasīt
2025. g. 31. dec. 17:16 UTC
OwlTing Climbs on Launch of $10M Stock-Buyback Program
DJ
Lasīt
2025. g. 31. dec. 17:15 UTC
Global Commodities Roundup: Market Talk
DJ
Lasīt
2025. g. 31. dec. 17:00 UTC
Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ
DJ
Lasīt
2025. g. 31. dec. 15:57 UTC
Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com
DJ
Lasīt
2025. g. 31. dec. 15:54 UTC
Layoff Data Supports Dollar at End of Losing Year -- Market Talk
DJ
Lasīt
2025. g. 31. dec. 15:02 UTC
Nike Shares Rise After CEO Hill Buys $1M of Shares
DJ
Lasīt
2025. g. 31. dec. 14:40 UTC
Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com
DJ
Lasīt
2025. g. 31. dec. 14:20 UTC
Crude Futures On Track to End the Year With Losses -- Market Talk
DJ
Lasīt
2025. g. 31. dec. 13:46 UTC
U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk
DJ
Lasīt
2025. g. 31. dec. 13:01 UTC
Charles Schwab Is Back on Offense. Its Stock Is a Buy. -- Barrons.com
DJ
Lasīt
2025. g. 31. dec. 11:10 UTC
Copper Remains in Touching Distance of Record Highs -- Market Talk
DJ
Lasīt
2025. g. 31. dec. 10:46 UTC
Euro on Track For Strong Annual Performance -- Market Talk
DJ
Lasīt
2025. g. 31. dec. 10:25 UTC
European Gas Prices Rise But Remain on Track for Heavy Annual Loss -- Market Talk
DJ
Lasīt
2025. g. 31. dec. 10:23 UTC
Chinese Yuan Rises to 31-Month High Against Dollar as Policymakers -- Market Talk
DJ
Lasīt
2025. g. 31. dec. 09:33 UTC
Dollar Set For Worst Annual Performance Since 2017 -- Market Talk
DJ
Lasīt
Cenas izmaiņa
By TipRanks
Prognoze 12 mēnešiem
Vidējais 50.59 USD 11.63%
Augstākais 55 USD
Zemākais 45 USD
Pamatojoties uz 14 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Qiagen NV — pēdējo 3 mēnešu laikā.
By TipRanks
Pirkt
14 ratings
8
Pirkt
6
Turēt
0
Pārdot
Pamatojoties uz 14 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Qiagen NV — pēdējo 3 mēnešu laikā.
By Acuity
Ziņu noskaņojums
Liecība "Buļļu" tendencei
Volatilitāte
Zem vidējā
Ziņu apjoms (RCV)
Zem vidējā
Pārdošanas un administrēšanas izmaksas
Darbības izmaksas
Peļņa pirms nodokļu nomaksas
Pārdošana
Pārdošanas maksa
Bruto peļņa no pārdošanas
Procentu izdevumi par parādu
EBITDA
Pamatdarbības peļņa
$